4.7 Review

Recent advances in microfluidic platforms for single-cell analysis in cancer biology, diagnosis and therapy

期刊

TRAC-TRENDS IN ANALYTICAL CHEMISTRY
卷 117, 期 -, 页码 13-26

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.trac.2019.05.010

关键词

Microfluidic lab-on-a-chip; Single cell analysis; Cancer biology; Cancer diagnosis; Cancer therapy; Cancer research

资金

  1. National Institute of Allergy and Infectious Disease of the NIH [R21AI107415]
  2. U.S. NSF-PREM program [DMR 1827745]
  3. Philadelphia Foundation
  4. Medical Center of the Americas Foundation
  5. National Institute of General Medical Sciences of the NIH [SC2GM105584]
  6. NIH RCMI Pilot grant
  7. University of Texas at El Paso
  8. University of Texas (UT) System

向作者/读者索取更多资源

Understanding molecular, cellular, genetic and functional heterogeneity of tumors at the single-cell level has become a major challenge for cancer research. The microfluidic technique has emerged as an important tool that offers advantages in analyzing single-cells with the capability to integrate time-consuming and labor-intensive experimental procedures such as single-cell capture into a single microdevice at ease and in a high-throughput fashion. Single-cell manipulation and analysis can be implemented within a multi-functional microfluidic device for various applications in cancer research. Here, we present recent advances of microfluidic devices for single-cell analysis pertaining to cancer biology, diagnostics, and therapeutics. We first concisely introduce various microfluidic platforms used for single-cell analysis, followed with different microfluidic techniques for single-cell manipulation. Then, we highlight their various applications in cancer research, with an emphasis on cancer biology, diagnosis, and therapy. Current limitations and prospective trends of microfluidic single-cell analysis are discussed at the end. (C) 2019 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据